financial post
Health Canada approves Celltrion’s Stoboclo® and Osenvelt®(CT-P41), denosumab biosimilars for the treatment of all indications approved for the reference products, Prolia® and Xgeva®, respectively
Financial Post • 3 MONTHS AGO
Trump and Xi are set to discuss the TikTok deal and future of US-China relations
Financial Post • 3 MONTHS AGO
AP Exclusive: Russia, Vietnam using energy profits to avoid possible US sanctions for arms deals
Financial Post • 3 MONTHS AGO
3 members of federal control board in Puerto Rico sue Trump and others for illegal firings
Financial Post • 3 MONTHS AGO